News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bender Jeremy
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 2,996 shares
@ $13.86, valued at
$41.5k
Exercised 3,562 restricted stock units
@ $0
Exercised 4,750 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Disposed of 240,288 shares
@ $0
Acquired 240,288 shares
@ $0
Gifted 240,288 shares
@ $0
Gifted 240,288 shares
@ $0
Gifted 240,288 shares
@ $0
Gifted 240,288 shares
@ $0
Gifted 59,737 shares
@ $0
Gifted 59,737 shares
@ $0
Gifted 29,938 shares
@ $0
Gifted 29,938 shares
@ $0 |
|
| 05/17/2023 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 3,104 shares
@ $13.1223, valued at
$40.7k
Exercised 3,562 restricted stock units
@ $0
Exercised 4,750 restricted stock units
@ $0 |
|
| 03/08/2023 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 12,500 shares
@ $20.0091, valued at
$250.1k
|
|
| 01/24/2023 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 12,500 shares
@ $21.999, valued at
$275k
|
|
| 01/19/2023 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Granted 244,000 options to buy
@ $20.87, valued at
$5.1M
Granted 76,000 restricted stock units
@ $0 |
|
| 11/22/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 12,100 shares
@ $20.7378, valued at
$250.9k
Sold 400 shares
@ $21.38, valued at
$8.6k
|
|
| 11/17/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 1,513 shares
@ $21.4598, valued at
$32.5k
Exercised 3,562 restricted stock units
@ $0 |
|
| 11/03/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 12,500 shares
@ $20.0284, valued at
$250.4k
|
|
| 10/05/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 12,500 shares
@ $20.0517, valued at
$250.6k
|
|
| 09/06/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 10,641 shares
@ $23.1514, valued at
$246.4k
Sold 1,859 shares
@ $23.7905, valued at
$44.2k
|
|
| 09/06/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 10,641 shares
@ $23.1514, valued at
$246.4k
Sold 1,859 shares
@ $23.7905, valued at
$44.2k
|
|
| 08/17/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 4,003 shares
@ $24.31, valued at
$97.3k
Exercised 10,686 restricted stock units
@ $0 |
|
| 08/05/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 12,500 shares
@ $20.0017, valued at
$250k
|
|
| 07/20/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 2,600 shares
@ $20.0012, valued at
$52k
|
|
| 07/12/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 1,795 shares
@ $20, valued at
$35.9k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Granted 397,000 options to buy
@ $14.26, valued at
$5.7M
Granted 57,000 restricted stock units
@ $0 |
|
| 05/26/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|